Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow Quality Index
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Quality Index of 3.41x as of December 2025. Operating cash flow of $360.04 Billion exceeds net income of $105.51 Billion, indicating high earnings quality where cash backs reported profits. Explore TAK debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Takeda Pharmaceutical Co Ltd ADR Cash Flow Quality Index (2000–2025)
Historical Cash Flow Quality Index for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see TAK operating cash flow.
Annual Cash Flow Quality Index for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year earnings quality comparison for Takeda Pharmaceutical Co Ltd ADR.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.80x | $1.06 Trillion | $107.93 Billion | ▲ +97.0% |
| 2024 | 4.97x | $716.34 Billion | $144.07 Billion | ▲ +61.3% |
| 2023 | 3.08x | $977.16 Billion | $317.04 Billion | ▼ -36.8% |
| 2022 | 4.88x | $1.12 Trillion | $230.17 Billion | ▲ +81.6% |
| 2021 | 2.69x | $1.01 Trillion | $376.17 Billion | ▼ -82.2% |
| 2020 | 15.12x | $669.75 Billion | $44.29 Billion | ▲ +401.9% |
| 2019 | 3.01x | $328.48 Billion | $109.01 Billion | ▲ +48.9% |
| 2018 | 2.02x | $377.85 Billion | $186.71 Billion | ▼ -10.6% |
| 2017 | 2.26x | $261.36 Billion | $115.51 Billion | ▲ +641.0% |
| 2016 | 0.31x | $25.49 Billion | $83.48 Billion | ▼ -77.4% |
| 2014 | 1.35x | $148.34 Billion | $109.56 Billion | ▼ -42.9% |
| 2013 | 2.37x | $307.71 Billion | $129.71 Billion | ▲ +78.0% |
| 2012 | 1.33x | $336.57 Billion | $252.48 Billion | ▲ +51.5% |
| 2011 | 0.88x | $326.94 Billion | $371.57 Billion | ▼ -4.0% |
| 2010 | 0.92x | $381.17 Billion | $415.83 Billion | ▲ +12.0% |
| 2009 | 0.82x | $326.27 Billion | $398.55 Billion | ▲ +61.5% |
| 2008 | 0.51x | $292.50 Billion | $576.84 Billion | ▲ +51.5% |
| 2007 | 0.33x | $209.28 Billion | $625.38 Billion | ▼ -53.6% |
| 2006 | 0.72x | $373.57 Billion | $517.96 Billion | ▲ +7.6% |
| 2005 | 0.67x | $295.54 Billion | $441.10 Billion | ▼ -3.9% |
| 2004 | 0.70x | $311.12 Billion | $446.14 Billion | ▲ +14.3% |
| 2003 | 0.61x | $263.45 Billion | $431.90 Billion | ▼ -40.3% |
| 2002 | 1.02x | $240.59 Billion | $235.66 Billion | ▲ +26.3% |
| 2001 | 0.81x | $212.66 Billion | $263.08 Billion | ▼ -39.2% |
| 2000 | 1.33x | $158.96 Billion | $119.62 Billion | — |